Zobrazeno 1 - 10
of 57
pro vyhledávání: '"T N Markova"'
Publikováno v:
Терапевтический архив, Vol 86, Iss 8, Pp 80-84 (2014)
AIM. To study the effect of metformin on metabolic parameters, body weight (BW), and waist circumference (WC) in patients with abdominal obesity (AO). MATERIALS AND METHODS. The results of using metformin 2000 mg daily for 3 months in 46 patients wit
Externí odkaz:
https://doaj.org/article/16faccfc50df4b3186d039de97c16780
Publikováno v:
Терапевтический архив, Vol 86, Iss 5, Pp 73-77 (2014)
AIM: To study the specific features of the hormonal status in the development of obesity and metabolic syndrome (MS) in different ethnic groups. Materials and methods. The prevalence of obesity and MS was studied in Russian and Chuvash people, the re
Externí odkaz:
https://doaj.org/article/c5f3e4cce3514ef0be51523e4727ea1d
Autor:
M. B. Antsiferov, O. N. Kotenko, Z. D. Kobalava, T. Y. Demidova, T. N. Markova, V. V. Tolkacheva, L. Y. Morgunov, A. V. Andreeva, E. Y. Pashkova, M. R. Khaziakhmetova, E. S. Samburova, S. G. Vedyashkina, A. M. Mkrtumyan, N. А. Petunina, А. N. Serebrov, T. M. Deeva, A. Y. Karaeva
Publikováno v:
Сахарный диабет, Vol 27, Iss 3, Pp 204-213 (2024)
AIM: To assess the prevalence of chronic kidney disease (CKD), clinical and demographic characteristics and therapy profile in patients with type 2 diabetes admitted to multidisciplinary hospitals. CREDO (Cardio-REnal Diabetic cOmplications) trial wa
Externí odkaz:
https://doaj.org/article/9acc7186593c4c55aed7d369c8c2532e
Autor:
T. N. Markova, M. S. Stas
Publikováno v:
Сахарный диабет, Vol 27, Iss 2, Pp 174-184 (2024)
Patients with type 2 diabetes mellitus (T2DM) are at high risk of adverse outcomes in coronavirus infection (COVID-19). Despite the gradual resolution of the pandemic, new strains of the virus are emerging, characterized by high contagiousness, and t
Externí odkaz:
https://doaj.org/article/ae97781e6ea94104a58794a1475d9f60
Autor:
M. B. Antsiferov, Zh. D. Kobalava, T. Y. Demidova, T. N. Markova, V. V. Tolkacheva, L. Y. Morgunov, A. V. Andreeva, Е. Y. Pashkova, M. R. Khaziakhmetova, E. S. Samburova, S. G. Vedyashkina, A. M. Mkrtumyan, N. А. Petunina, A. N. Serebrov, T. M. Deeva, A. Y. Karaeva
Publikováno v:
Сахарный диабет, Vol 27, Iss 1, Pp 4-14 (2024)
BACKROUND: Heart failure (HF) is in the first place in the structure of cardiovascular death in patients with type 2 diabetes mellitus (T2D). One of the factors determining the prognosis of patients with this pathology is hospitalization. The difficu
Externí odkaz:
https://doaj.org/article/d5cde38ed9fb487b9cd59a4a1e637bcf
Publikováno v:
Сахарный диабет, Vol 26, Iss 6, Pp 585-595 (2023)
Metformin, known in the medical community as the drug of first choice for type 2 diabetes mellitus, belongs to the group of biguanides and has proven to be an effective treatment in clinical practice. Our knowledge of the pharmacodynamic properties o
Externí odkaz:
https://doaj.org/article/22e635b6c2d9481bb298ea809e279f27
Publikováno v:
Сахарный диабет, Vol 26, Iss 6, Pp 537-548 (2023)
BACKGROUND. The search for new effective methods of treatment and prevention of COVID-19 in patients with type 2 diabetes mellitus (T2DM) remains an urgent task for the healthcare system.AIM. To evaluate the efficacy and safety of initiating of gluca
Externí odkaz:
https://doaj.org/article/84b9190f906341bb802791ec6db117a7
Publikováno v:
Сахарный диабет, Vol 26, Iss 4, Pp 363-369 (2023)
Patients with type 1 Diabetes Mellitus (T1DM) on renal replacement therapy with maintenance hemodialysis (MHD) are prone to develop hypoglycemia, as well as high glycemic variability on both dialysis and non-dialysis days. Reliability of glycated hem
Externí odkaz:
https://doaj.org/article/ab9003cf19bb4792884ea0001bb005a1
Autor:
M. B. Antsiferov, G. R. Galstyan, T. Yu. Demidova, A. V. Zilov, T. N. Markova, А. M. Mkrtumyan, N. A. Petunina, I. S. Khalimov, M. S. Shamkhalova, M. V. Shestakova
Publikováno v:
Сахарный диабет, Vol 26, Iss 2, Pp 211-214 (2023)
Type 2 diabetes is characterized by increasing incidence and prevalence all-over the world. Current therapeutic management of type 2 diabetes is complex and is based not only on glycemic control, but also on cardiovascular and renal risks reduction.
Externí odkaz:
https://doaj.org/article/d859b678f86d4281a70004385fe60c28
Autor:
I. E. Chazova, Yu. V. Zhernakova, N. V. Blinova, T. N. Markova, N. V. Mazurina, I. V. Zhirov, T. M. Uskach, A. A. Safiullina, O. Iu. Mironova, E. M. Elfimova, A. Yu. Litvin, E. A. Zheleznova, Yu. A. Yuricheva, V. A. Azizov, E. A. Grigorenko, Z. Ya. Rahimov, S. D. Kasymova, I. I. Mustafaev, A. R. Narzullaeva, A. G. Polupanov, A. Sh. Sarybaev, N. Z. Srozhidinova
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 3, Pp 6-56 (2022)
Disclaimer. The EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC is not responsible in the event
Externí odkaz:
https://doaj.org/article/b4400d16e0f04821a82c5e569b0dd6a8